Upstream Bio, Inc. (UPB) Revenue Growth
Upstream Bio, Inc. (UPB) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2024-12-31 | -0.42% |
| 2025-12-31 | 20.42% |
How UPB compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| MOH | Molina Healthcare Inc | 11.75% |
| UTHR | United Therapeutics Corporation | 10.61% |
| VNDA | Vanda Pharmaceuticals Inc. | 8.72% |
| ACHC | Acadia Healthcare Company Inc. | 5.04% |
| ZTS | Zoetis Inc. Class A | 2.28% |
These are five companies in the same sector as UPB with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Upstream Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("UPB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | UPB | $6.55 | -1.06% | 0.48M |
| 3 | ||||
| 4 | ||||
| 5 |